Table 4.
NYULMC 2016–2017 (n=53) N (%) |
MSKCC 2011–2013 (n=232) N (%) |
|||||
---|---|---|---|---|---|---|
Stage Group |
TNM | TNM+Biomarkers | TNM+Biomarker+RS<11 | TNM | TNM+Biomarkers | TNM+Biomarker+RS<11 |
IA | 41 (77.4) | 51 (96.2) | 53 (100) | 214 (92.2) | 232 (100) | 232 (100) |
IB | 0 (0) | 2 (3.8) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
IIA | 12 (22.6) | 0 (0) | 0 (0) | 18 (7.8) | 0 (0) | 0 (0) |